ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 57 filers reported holding ABEONA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,000 | -74.1% | 93,987 | -71.8% | 0.00% | – |
Q4 2021 | $112,000 | -44.8% | 332,712 | +155.4% | 0.00% | – |
Q2 2021 | $203,000 | -60.4% | 130,266 | -52.3% | 0.00% | – |
Q1 2021 | $513,000 | -88.7% | 272,902 | -90.6% | 0.00% | -100.0% |
Q4 2020 | $4,546,000 | +321.7% | 2,895,256 | +173.8% | 0.00% | – |
Q3 2020 | $1,078,000 | -75.5% | 1,057,242 | -29.8% | 0.00% | -100.0% |
Q2 2020 | $4,393,000 | +48.8% | 1,506,793 | +7.2% | 0.00% | +100.0% |
Q1 2020 | $2,952,000 | +86.7% | 1,405,752 | +190.8% | 0.00% | 0.0% |
Q4 2019 | $1,581,000 | +61.3% | 483,474 | +11.5% | 0.00% | – |
Q3 2019 | $980,000 | -65.1% | 433,425 | -26.2% | 0.00% | -100.0% |
Q2 2019 | $2,809,000 | +268.6% | 587,623 | +467.8% | 0.00% | – |
Q1 2019 | $762,000 | -13.0% | 103,500 | -15.7% | 0.00% | – |
Q4 2018 | $876,000 | -42.0% | 122,800 | +4.1% | 0.00% | – |
Q3 2018 | $1,510,000 | -16.2% | 118,006 | +4.8% | 0.00% | – |
Q2 2018 | $1,802,000 | -92.6% | 112,573 | -93.4% | 0.00% | -100.0% |
Q1 2018 | $24,452,000 | +3204.3% | 1,704,003 | +3550.8% | 0.01% | – |
Q4 2017 | $740,000 | -97.1% | 46,675 | -96.8% | 0.00% | -100.0% |
Q3 2017 | $25,136,000 | +19087.8% | 1,474,229 | +5332.3% | 0.02% | – |
Q4 2016 | $131,000 | – | 27,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 88,629 | $269,000 | 0.16% |
IFP Advisors, Inc | 0 | $175,000 | 0.01% |
CAMBRIDGE TRUST CO | 65,073 | $12,000 | 0.00% |